Stocksigma LogoStocksigma Logo

Symbiotec Secures 10-Year Take-or-Pay Alternative Protein CDMO Contract

Symbiotec Pharmalab entered into a 10-year, take-or-pay CDMO agreement with a European alternative protein innovator to manufacture precision

Symbiotec Secures 10-Year Take-or-Pay Alternative Protein CDMO Contract

Symbiotec Pharmalab Ltd 路 Others (Uncategorized) 路 06 Nov 2026, 3:24 pm

Symbiotec Secures 10-Year Take-or-Pay Alternative Protein CDMO Contract Symbiotec Pharmalab entered into a 10-year, take-or-pay CDMO agreement with a European alternative protein innovator to manufacture precision fermentation-based protein. Production will be based at Symbiotec鈥檚 Ujjain campus, utilizing four 100 kL fermenters with integrated downstream processing and quality control. Initial manufacturing will commence at the existing facility, followed by a dedicated plant adding several hundred thousand litres of fermentation capacity, alongside contracted expansion options extending into millions of litres. Financial consideration remains undisclosed due to confidentiality obligations.

Original exchange filing (PDF)

More announcements from Symbiotec Pharmalab Ltd

All Symbiotec Pharmalab Ltd announcements